As of Oct 06
| -0.73 / -15.47%|
The 1 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 6.80, with a high estimate of 6.80 and a low estimate of 6.80. The median estimate represents a +70.43% increase from the last price of 3.99.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.